T0	Participants 70 150	children with pervasive developmental disorders and serious behavioral problems.
T1	Participants 162 216	Children with Pervasive Developmental Disorders (PDDs)
T2	Participants 509 656	124 children (4 through 13 years of age) with PDDs and serious behavioral problems to medication alone (MED; n = 49; risperidone 0.5 to 3.5 mg/day;
T3	Participants 784 852	Parents of children in COMB received an average of 11.4 PT sessions.
T4	Participants 987 1060	Seventeen subjects did not have a post-randomization Vineland assessment.
T5	Participants 2141 2189	Children With Pervasive Developmental Disorders;